Last reviewed · How we verify

NCT06134700

Low Pressure Versus Standard Pressure Pneumoperitoneum in Laparoscopic Nephrectomy

Status unknown NA Last updated 18 November 2023
What this trial tests

NA trial testing Laparoscopic Surgery in Non-Functioning Kidney in 44 participants. Status unknown.

Timeline
15 November 2023
Primary endpoint
15 August 2024
15 December 2024

Quick facts

Lead sponsorInstitute of medicine, Maharagjung medical campus
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment44
Start date15 November 2023
Primary completion15 August 2024
Estimated completion15 December 2024

Drugs / interventions tested

Conditions studied

Sponsor

Institute of medicine, Maharagjung medical campus

Who can join

18 and older, any sex, with Non-Functioning Kidney or Renal Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laparoscopic nephrectomies are commonly performed these days and are considered gold standard for both benign and malignant diseases as well as for donor nephrectomies. Despite being a widely performed surgery worldwide still there are areas of uncertainties due to lack of evidences. One of such area of dilemma is the optimum pressure of pneumoperitoneum. This study aims to identify if lower pressure of pneumoperitoneum is safe during laparoscopic nephrectomies. This is a hospital based prospective randomized control study. All the patients undergoing laparoscopic nephrectomies at department of urology and kidney transplant surgery will be eligible for study. Patients will be divided into low pressure or standard pressure pneumoperitoneum by simple random sampling and comparison of various intraoperative and post-operative parameters will be done to assess the safety of low pressure pneumoperitoneum

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Laparoscopic Surgery

Trials testing the same drug.

Other Institute of medicine, Maharagjung medical campus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06134700.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing